LEADER 03184nam  2200649 a 450 
001 9910813224803321
005 20240417005424.0
010   $a0-309-20961-7
010   $a1-283-01913-2
010   $a9786613019134
010   $a0-309-16183-5
035   $a(CKB)2550000000032005
035   $a(SSID)ssj0000536379
035   $a(PQKBManifestationID)11325251
035   $a(PQKBTitleCode)TC0000536379
035   $a(PQKBWorkID)10549347
035   $a(PQKB)10134841
035   $a(MiAaPQ)EBC3378741
035   $a(Au-PeEL)EBL3378741
035   $a(CaPaEBR)ebr10454959
035   $a(CaONFJC)MIL301913
035   $a(OCoLC)923283111
035   $a(EXLCZ)992550000000032005
100   $a20110408d2011      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aEstablishing precompetitive collaborations to stimulate genomics-driven product development $eworkshop summary /$fInstitute of Medicine of the National Academies ; Steve Olson and Adam C. Berger, rapporteurs
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$d2011
215   $axv, 74 p. $cill. (some col.)
300   $a"Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy."
311   $a0-309-16182-7 
320   $aIncludes bibliographical references.
327   $aIntroduction -- A lesson about precompetitive collaboration -- Requisites for successful precompetitive collaboration -- Frameworks for collaboration -- The use of biospecimens in precompetitive collaborations -- Ethical challenges in the use of biospecimens -- Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration.
330   $a"Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions."--Publisher's description.
606   $aPharmacogenetics$vCongresses
606   $aDrug development$vCongresses
606   $aGenomics$vCongresses
615  0$aPharmacogenetics
615  0$aDrug development
615  0$aGenomics
676   $a576.5
701   $aOlsen$b Steven$01602366
701   $aBerger$b Adam C$01120088
712 02$aInstitute of Medicine (U.S.).$bRoundtable on Translating Genomic-Based Research for Health.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
712 12$aEstablishing Precompetitive Collaborations to stimulate genomics-driven product development$f(2010 :$eWashington, D.C.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910813224803321
996   $aEstablishing precompetitive collaborations to stimulate genomics-driven product development$93950256
997   $aUNINA